Novan Stock Falls After Raising $40M Via Equity At 21% Discount

Novan Inc (NASDAQ: NOVN) priced its previously announced public offering of 3.6 million shares at $11/share for gross proceeds of approximately $40 million.
The offer price represents a 21% discount on the last close price of $13.85 on Wednesday. The offering will close by June 21.
Underwriters have an option to purchase up to 545k additional shares.
Cantor Fitzgerald & Co. is acting as the sole book-running manager for the offering.
Novan intends to use the net proceeds to fund the R&D of SB206, as well as for general corporate purposes.
Last week, the company announced positive topline efficacy and safety results from the Phase 3 trial of SB206 for molluscum contagiosum.
Price Action: NOVN shares are down 20.9% at $10.96 during the market session on the last check Thursday.

See more from Benzinga

Click here for options trades from Benzinga
Novan's Stock Surges As SB206 Can Potentially Shorten Duration Of Contagious Skin Disease